title: Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
abstract: Visceral leishmaniasis is infrequently reported in renal transplant recipients. A 40-year-old renal transplant recipient developed hepatosplenomegaly and pyrexia of unknown origin 5 months after transplantation. Visceral leishmaniasis was confirmed on bone marrow examination. The usual dose of antiparasitic therapy with stibogluconate sodium failed to eradicate Leishmania donovani. High-dose conventional therapy with stibogluconate sodium for an extended period of time was successful in the treatment of a relapse of leishmaniasis.
authors: Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
authors: R K
authors: RK
authors: Sharma
authors: R
authors: R
authors: Jha
authors: P
authors: P
authors: Kumar
authors: V
authors: V
authors: Kher
authors: A
authors: A
authors: Gupta
authors: A
authors: A
authors: Kumar
authors: S
authors: S
authors: Gulati
authors: P
authors: P
authors: Arora
authors: M
authors: M
authors: Murari
authors: M
authors: M
authors: Bhandari
mesh_terms: D000328:Adult; D000967:Antimony Sodium Gluconate / Q000008:administration & dosage; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D007898:Leishmaniasis, Visceral / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000981:Antiprotozoal Agents; D000967:Antimony Sodium Gluconate